bioAffinity Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.

About BIAF

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. 

CEO
Maria Zannes
CEOMaria Zannes
Employees
57
Employees57
Headquarters
San Antonio, Texas
HeadquartersSan Antonio, Texas
Founded
2014
Founded2014
Employees
57
Employees57

BIAF Key Statistics

Market cap
5.10M
Market cap5.10M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
—
Dividend yield—
Average volume
3.81M
Average volume3.81M
High today
$4.82
High today$4.82
Low today
$3.06
Low today$3.06
Open price
$3.50
Open price$3.50
Volume
892.18K
Volume892.18K
52 Week high
$80.70
52 Week high$80.70
52 Week low
$3.06
52 Week low$3.06

Stock Snapshot

With a market cap of 5.1M, bioAffinity Technologies(BIAF) trades at $3.52. The stock has a price-to-earnings ratio of -0.04.

As of 2026-10-13, bioAffinity Technologies(BIAF) stock has fluctuated between $3.06 and $4.82. The current price stands at $3.52, placing the stock +15.0% above today's low and -27.0% off the high.

The bioAffinity Technologies(BIAF)'s current trading volume is 892.18K, compared to an average daily volume of 3.81M.

During the past year, bioAffinity Technologies(BIAF) stock moved between $3.06 at its lowest and $80.70 at its peak.

During the past year, bioAffinity Technologies(BIAF) stock moved between $3.06 at its lowest and $80.70 at its peak.

BIAF News

TipRanks 11h
bioAffinity to Present New Sputum-Based Lung Biomarker Data

bioAffinity Technologies, Inc. ( (BIAF) ) has issued an announcement. On October 13, 2026, bioAffinity Technologies announced it will present new research data...

TipRanks 4d
bioAffinity Technologies Completes New $4 Million Financing - TipRanks

...

bioAffinity Technologies Completes New $4 Million Financing - TipRanks
TipRanks 4d
BioAffinity Technologies announces closing of $4M registered direct financing

bioAffinity Technologies (BIAF) announced that it has closed its previously announced registered direct offering of shares of common stock with an institutional...

People also own

Based on the portfolios of people who own BIAF. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.